Abstract
Because pandemic influenza virus infection can result in large-scale human death and have a major economic impact, influenza virus is one of the most important microbial pathogens. To control influenza virus, both clarification of the mechanisms by which the virus causes disease and the development of effective drugs and other therapies based on these mechanisms are needed. Virus infection often induces cell death, which can play an important role in disease pathogenesis, and influenza virus, in particular, has been shown to induce significant levels of apoptosis in vivo and in vitro. Over the past decade, the mechanisms by which viral and cellular factors modulate apoptosis induction in influenza virus-infected cells have been revealed. Viral proteins such as hemagglutinin, neuraminidase, M1, NS1, and PB1-F2 have been shown to be involved in apoptosis induction through extrinsic or intrinsic apoptotic pathways. On the other hand, several drugs with different mechanisms of action and a neutralizing monoclonal antibody (mAb) are currently used to control influenza virus. A better understanding of both how influenza virus infects host cells and the intracellular signaling pathways that are activated by infection is essential for the development of antiviral drugs and other effective therapies.
Keywords: Apoptosis, drugs, haemagglutinin, H5N1, influenza virus, therapies
Current Chemical Biology
Title: The Role of Apoptosis in Influenza Virus Pathogenesis and the Mechanisms Involved in Anti-Influenza Therapies
Volume: 4 Issue: 3
Author(s): Tomo Daidoji, Kunihiro Kaihatsu and Takaaki Nakaya
Affiliation:
Keywords: Apoptosis, drugs, haemagglutinin, H5N1, influenza virus, therapies
Abstract: Because pandemic influenza virus infection can result in large-scale human death and have a major economic impact, influenza virus is one of the most important microbial pathogens. To control influenza virus, both clarification of the mechanisms by which the virus causes disease and the development of effective drugs and other therapies based on these mechanisms are needed. Virus infection often induces cell death, which can play an important role in disease pathogenesis, and influenza virus, in particular, has been shown to induce significant levels of apoptosis in vivo and in vitro. Over the past decade, the mechanisms by which viral and cellular factors modulate apoptosis induction in influenza virus-infected cells have been revealed. Viral proteins such as hemagglutinin, neuraminidase, M1, NS1, and PB1-F2 have been shown to be involved in apoptosis induction through extrinsic or intrinsic apoptotic pathways. On the other hand, several drugs with different mechanisms of action and a neutralizing monoclonal antibody (mAb) are currently used to control influenza virus. A better understanding of both how influenza virus infects host cells and the intracellular signaling pathways that are activated by infection is essential for the development of antiviral drugs and other effective therapies.
Export Options
About this article
Cite this article as:
Daidoji Tomo, Kaihatsu Kunihiro and Nakaya Takaaki, The Role of Apoptosis in Influenza Virus Pathogenesis and the Mechanisms Involved in Anti-Influenza Therapies, Current Chemical Biology 2010; 4 (3) . https://dx.doi.org/10.2174/2212796811004030208
DOI https://dx.doi.org/10.2174/2212796811004030208 |
Print ISSN 2212-7968 |
Publisher Name Bentham Science Publisher |
Online ISSN 1872-3136 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
A Review of Recent Patents Concerning Therapy of Respiratory Diseases Using Gene Silencing by RNAi (RISC) and EGS (RNAse P)
Recent Patents on Inflammation & Allergy Drug Discovery Importance of Environmental Factors on Production of Computationally- Defined Natural Molecules against COVID-19 Pandemic
Current Topics in Medicinal Chemistry Mitochondrial Dysfunction and Antioxidant Therapy in Sepsis
Infectious Disorders - Drug Targets Molecular Docking: Challenges, Advances and its Use in Drug Discovery Perspective
Current Drug Targets Base-Modified Nucleosides as Chemotherapeutic Agents: Past and Future
Current Topics in Medicinal Chemistry Insulin Resistance, Oxidative Stress and Cardiovascular Complications: Role of Sirtuins
Current Pharmaceutical Design Combinatorial Approaches for the Identification of Brain Drug Delivery Targets
Current Pharmaceutical Design Adult Neurogenesis in Mesial Temporal Lobe Epilepsy: A Review of Recent Animal and Human Studies
Current Pharmaceutical Biotechnology Hijacking the Hedgehog Pathway in Cancer Therapy
Anti-Cancer Agents in Medicinal Chemistry Polymorphisms in TOLL-Like Receptor Genes and their Roles in Allergic Asthma and Atopy
Recent Patents on Inflammation & Allergy Drug Discovery Paclitaxel (Taxol) and Taxoid Derivates for Lung Cancer Treatment: Potential for Aerosol Delivery
Current Cancer Drug Targets Biomarker-Guided Strategy for Treatment of Autism Spectrum Disorder (ASD)
CNS & Neurological Disorders - Drug Targets High Altitude Hypoxia
Current Proteomics Manipulation of Biliary Lipids by Gene Therapy: Potential Consequences for Patients with Progressive Familial Intrahepatic Cholestasis
Current Drug Targets - Immune, Endocrine & Metabolic Disorders Use of Exogenous Enzymes in Human Therapy: Approved Drugs and Potential Applications
Current Medicinal Chemistry Merging Transport Data for Choroid Plexus with Blood-Brain Barrier to Model CNS Homeostasis and Disease More Effectively
CNS & Neurological Disorders - Drug Targets Patient-derived Tumor Models for Diffuse Intrinsic Pontine Gliomas
Current Neuropharmacology Medical Treatment for Neurocysticercosis: Drugs, Indications and Perspectives
Current Topics in Medicinal Chemistry Inhibitory Role of Resveratrol in the Development of Profibrogenesis and Fibrosis Mechanisms
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Challenging the Evidence Based Medicine Principles Among Clinical Obesity Treatments
Current Clinical Pharmacology